2024 coding update
Pediatricians may eventually realize a significant increase in income by attaching the G2211 code to acute and chronic care visits.
Novel genetic therapies for sickle cell disease and β-thalassemia
As safe and effective gene-editing and gene-replacement therapies become more attainable, developing the delivery systems that ensure these treatments are equitably available will be equally essential.
CDC suggests doxycycline postexposure prophylaxis for STI prevention
Following evidence from recent studies, the CDC has recommended the use of doxycycline postexposure prophylaxis in sexual health among certain populations.
Now available: upadacitinib to treat JIA, psoriatic arthritis in patients 2 years and up
Additionally, a new weight-based oral solution, RINVOQ LQ, is now available as an option for the pediatric populations.
Use of monoclonal antibodies for idiopathic chronic eosinophilic pneumonia
Management of ICEP with monoclonal antibodies against IL-5 and IgE (omalizumab) could be promising according to study authors, though extent of evidence is lacking.
BLA for steroid-refractory acute graft versus host disease candidate to be resubmitted
Mesoblast Limited's chief executive announced a BLA resubmission for remestemcel-L is expected to be filed with the FDA this quarter.
FDA approves increased amifampridine maximum daily dose to treat Lambert-Eaton myasthenic syndrome
The maximum daily dose has increased from 80 mg to 100 mg.
What to expect in the June issue of Contemporary Pediatrics
Editor-in-chief Tina Tan, MD, FAAP, FIDSA, FPIDS, highlights the June 2024 issue of Contemporary Pediatrics.
Weekly review: ADHD treatment FDA approval, peanut consumption and adolescent tolerance, and more
Get caught up with our journal! Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.
Spike in PTSD, acute stress disorder observed among college students from 2017-2022
The disorders can impact the academic and social functioning of college students and have been associated with long-term health issues.
Belimumab autoinjector approved for systemic lupus erythematosus patients 5 years and older
Prior to the federal agency's decision, children aged 5 years and older could only receive belimumab through an intravenous (IV) formulation.
Selpercatinib approved for solid tumor, RET-altered metastatic thyroid cancer patients 2 years and older
The therapy was previously granted accelerated approval for the thyroid cancer indications in adults and pediatric patients aged 12 years and older.
Associations between childhood asthma and dietary intake, minerals, vitamins, antioxidants
Analysis demonstrated a significant correlation between elevated levels of serum circulating magnesium and serum vitamin D with increased risk of childhood asthma.
FDA approves clonidine hydrochloride to treat ADHD in patients 6 years and up
The once daily extended-release oral suspension with nighttime dosing is approved to treat ADHD as a monotherapy or as an adjunctive therapy to approved CNS stimulant medications.
Peanut consumption through 5 years of age provides lasting tolerance into adolescence
Peanut consumption starting in infancy resulted in lasting tolerance into adolescence.
Early adolescents with complex congenital heart disease have higher stress markers
Findings indicate that chronically high stress markers could have a role in the development of EF impairments in early adolescents with cCHD.
Study: Ultraprocessed food increases cardiovascular risk in children
A recent study suggests that high ultraprocessed food consumption in preschool children is linked to increased cardiometabolic risk factors.
Adolescent borderline personality disorder linked to high risk of ADHD, schizophrenia in later years
New international findings show BPD diagnosis in teenaged years may be a critical indicator of subsequent mental disorder into young adulthood.
Weekly review: Teen caffeine intake, GLP-1 prescriptions, and more
Adolescent GLP-1 prescriptions increased 6-fold from 2020 to 2023
Drugs like semaglutide and liraglutide were dispensed at unprecedented increased rates for adolescents and young adults over a span of just 4 years.
Depression not increased by gender identity changes in adolescents
Approximately 1 in 5 youths who identify as a sexual gender minority will undergo a gender identity change in their adolescence; however, such changes do not appear to impact their mental health.
Integrating behavioral health within primary care settings
Donna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN, shares her thoughts on the latest issue of Contemporary Pediatrics and how these articles can be utilized in the everyday practice of PNPs.
Sun burn consequences and sunscreen recommendations for children
Wendy Ripple, MD, provides suggestions for sunscreens in the pediatric population.
Prenatal opioid exposure could have long-term impact on immune system
In the retrospective, population-based cohort study, the investigators used linked administrative health records of all children born in Western Australia between January 1, 2003 and December 31, 2018 (n = 401,462).
Weekly review: FDA news, hypertension studies, and more
Children with hypertension at higher risk of associated major adverse cardiac events
Children with hypertension were at an increased risk of stroke, congestive heart failure, and other major adverse cardiac events compared to non-hypertensive individuals.
Practical reminders for sunscreen recommendations, sun safety as summer approaches
As children head outside for summer, providers can remind parents of some staple sun safety tips.
FDA expands label for lipid injectable emulsion to preterm and term neonates
Approximately 40% of patients who receive PN in the United States as an intravenous source of nourishment are under 18 years of age.
T2D risk increased with increased HbA1c levels among adolescents with overweight, obesity
Investigators found that higher baseline HbA1c was associated with greater T2D risk.
Study lays groundwork for potential vaccine customized for children with recurrent eczema flares
These data from investigators at Trinity College Dublin highlighted the immune response mechanisms visible in children with atopic dermatitis.
